Utah Medical Products Inc
UTMD· Nasdaq
Released Apr 25, 2023, after the close
10-Q filed May 5, 2023, 35 days after period end · 0001811884-23-000013
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $12.52M | $12.32M | $10.96M | $10.90M |
| Net Income | $4.21M | $3.53M | $3.02M | $3.14M |
| EPS Diluted |
Utah Medical Products Inc · CIK 706698 · Engraved from SEC EDGAR
| $1.16 |
| $0.96 |
| $0.83 |
| $0.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.